DAWN Live signals | Maximize Profits with Getagraph.com

BUY 113944 min ago

@ $14.66

Issued: 14 Feb 2024 @ 15:53

Return: 17.12%

Previous signal: Feb 14 - 09:31

Previous signal: Sell

Return: 1.24 %

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 16:00):

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers...

Stats
Today's Volume	1.15M
Average Volume	1.03M
Market Cap	1.50B
EPS	$0 ( 2024-03-04 )
Next earnings date	( $-0.670 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.24
ATR14	$0.0150 (0.09%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Bender Jeremy	Sell	70 051	Common Stock
2024-05-02	Bender Jeremy	Sell	6	Common Stock
2024-05-03	Bender Jeremy	Sell	9 154	Common Stock
2024-05-01	York Charles N Ii	Sell	52 183	Common Stock
2024-05-02	York Charles N Ii	Sell	200	Common Stock

INSIDER POWER
46.21
Last 96 transactions
Buy: 3 404 081 \| Sell: 1 304 949

Volume Correlation

Long: -0.12 (neutral)

Short: -0.07 (neutral)

Signal:(40.964) Neutral

Day One Correlation

10 Most Positive Correlations
CASA	0.96
ESPR	0.953
ALT	0.952
KZR	0.952
SONN	0.95
ACER	0.949
MRBK	0.949
AHPI	0.948
IOBT	0.944
PFSW	0.943

10 Most Negative Correlations
STAY	-0.966
DSPG	-0.963
DVCR	-0.947
LMNX	-0.947
OPNT	-0.942
RAM	-0.94
NTUS	-0.935
AMYT	-0.935
COCO	-0.928
CPTA	-0.928

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Day One Correlation - Currency/Commodity

0.68
( moderate )

0.71
( moderate )

0.00
( neutral )

0.07
( neutral )

0.35
( neutral )

Day One Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-383 000 (0.00 %)
EPS:	$-2.37

FY	2023
Revenue:	$0
Gross Profit:	$-383 000 (0.00 %)
EPS:	$-2.37

FY	2022
Revenue:	$0
Gross Profit:	$-531 000 (0.00 %)
EPS:	$-2.02

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-4.62

Financial Reports:

No articles found.

Day One

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.

Realtime updates for Day One [DAWN]

Upcoming Earnings Alert